Literature DB >> 1483048

Neonatal seizures and severe hypotonia in a male infant suffering from a defect in peroxisomal beta-oxidation.

L Van Maldergem1, M Espeel, R J Wanders, F Roels, P Gerard, E Scalais, G P Mannaerts, M Casteels, Y Gillerot.   

Abstract

In this paper, we describe a baby male born to healthy non-consanguineous parents presenting at birth with hypotonia and seizures. Additional salient clinical features included the development of glaucoma, the absence of significant facial dysmorphism and the absence of liver enlargement or renal cysts. The patient died at the age of 3 months. At autopsy, liver fibrosis and kidney glomerulosclerosis were noted. Neuropathological findings included pachygyria of the olivary nuclei and cerebellar neuronal heterotopias. There was no evidence for a demyelinating process. Biochemically, the patient was found to have elevated plasma levels of very-long-chain fatty acids (VLCFA) and abnormal bile acid intermediates, whereas other indicators of peroxisomal function (plasmalogen biosynthesis and plasma pipecolic acid) were normal. Catalase staining of a liver biopsy specimen revealed peroxisomes to be present in normal numbers, although some were abnormally large. Trilamellar inclusions typical of a peroxisomal fatty acid oxidation defect were present in macrophages. Indeed, beta-oxidation of the very-long-chain fatty acid hexacosanoic acid (C26:0) was found to be strongly deficient. Fatty acyl-CoA oxidase activity in the patient's liver was normal, however. Furthermore immunocytochemical studies using antibodies against acyl-CoA oxidase, bifunctional protein and peroxisomal thiolase, revealed the normal localization of all three enzyme proteins within the peroxisomes. We suggest that our patient has a selective peroxisomal beta-oxidation defect, a recently identified heterogeneous group of early-onset peroxisomal disorders distinct from the Zellweger syndrome and other generalized peroxisomal disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483048     DOI: 10.1016/0960-8966(92)90009-u

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Lipid homeostasis and inflammatory activation are disturbed in classically activated macrophages with peroxisomal β-oxidation deficiency.

Authors:  Ivana Geric; Yulia Y Tyurina; Olga Krysko; Dmitri V Krysko; Evelyn De Schryver; Valerian E Kagan; Paul P Van Veldhoven; Myriam Baes; Simon Verheijden
Journal:  Immunology       Date:  2017-10-26       Impact factor: 7.397

2.  Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system.

Authors:  Steven Huyghe; Henning Schmalbruch; Leen Hulshagen; Paul Van Veldhoven; Myriam Baes; Dieter Hartmann
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 3.  Neuropathology of peroxisomal diseases.

Authors:  J J Martin
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 4.  Practical guide for morphometry of human peroxisomes on electron micrographs.

Authors:  I Kerckaert; D De Craemer; G Van Limbergen
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells.

Authors:  R J Wanders; R Ofman; G J Romeijn; R B Schutgens; P A Mooijer; C Dekker; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.

Authors:  R J Wanders; S Denis; J P Ruiter; R B Schutgens; C W van Roermund; B S Jacobs
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.